tradingkey.logo

Labcorp Holdings Inc

LH
View Detailed Chart

275.925USD

-2.025-0.73%
Market hours ETQuotes delayed by 15 min
22.87BMarket Cap
29.96P/E TTM

Labcorp Holdings Inc

275.925

-2.025-0.73%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.73%

5 Days

-0.99%

1 Month

+1.72%

6 Months

+15.19%

Year to Date

+20.32%

1 Year

+24.78%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated2025-09-12

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
5 / 72
Overall Ranking
87 / 4724
Industry
Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 21 analysts
Buy
Current Rating
294.772
Target Price
+6.05%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 32.56%.
Fairly Valued
The company’s latest PE is 30.42, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 81.46M shares, decreasing 6.24% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 9.84M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.29.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Ticker SymbolLH
CompanyLabcorp Holdings Inc
CEOMr. Adam H. Schechter
Websitehttps://www.labcorp.com/
KeyAI